UK markets closed

PCI Biotech Holding ASA (PCIB.OL)

Oslo - Oslo Delayed price. Currency in NOK
Add to watchlist
1.5860+0.0360 (+2.32%)
At close: 03:05PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
15,627
15,627
44,756
71,707
75,571
Selling general and administrative
9,604
9,604
16,441
20,595
13,917
Total operating expenses
22,241
22,241
56,447
86,029
82,120
Operating income or loss
-22,241
-22,241
-56,447
-86,029
-82,120
Interest expense
159
159
127
89
397
Income before tax
-20,315
-20,315
-55,095
-88,391
-72,239
Income tax expense
0
0
0
0
0
Income from continuing operations
-20,315
-20,315
-55,095
-88,391
-72,239
Net income
-20,315
-20,315
-55,095
-88,391
-72,239
Net income available to common shareholders
-20,315
-20,315
-55,095
-88,391
-72,239
Basic EPS
-0.79
-
-1.48
-2.37
-1.94
Diluted EPS
-0.79
-
-1.48
-2.37
-1.94
Basic average shares
37,326
-
37,326
37,326
37,285
Diluted average shares
37,326
-
37,326
37,326
37,285